Filing Details
- Accession Number:
- 0001415889-23-015446
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-22 18:07:37
- Reporting Period:
- 2023-11-20
- Accepted Time:
- 2023-11-22 18:07:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1583107 | Theravance Biopharma Inc. | TBPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1898490 | Rhonda Farnum | C/O Theravance Biopharma Us, Inc. 901 Gateway Blvd South San Francisco CA 94080 | Svp, Comm & Medical Affairs | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2023-11-20 | 7,982 | $10.37 | 332,584 | No | 4 | F | Direct | |
Ordinary Shares | Disposition | 2023-11-21 | 1,378 | $10.29 | 331,206 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.
- This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 03/09/2023.